| __timestamp | BioMarin Pharmaceutical Inc. | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 461543000 | 7459000 |
| Thursday, January 1, 2015 | 634806000 | 11831000 |
| Friday, January 1, 2016 | 661905000 | 25705000 |
| Sunday, January 1, 2017 | 610753000 | 46181000 |
| Monday, January 1, 2018 | 696328000 | 59497000 |
| Tuesday, January 1, 2019 | 715007000 | 65003000 |
| Wednesday, January 1, 2020 | 628116000 | 74506000 |
| Friday, January 1, 2021 | 628793000 | 126006000 |
| Saturday, January 1, 2022 | 649606000 | 126215000 |
| Sunday, January 1, 2023 | 746773000 | 120161000 |
Unlocking the unknown
In the ever-evolving world of pharmaceuticals, innovation is the lifeblood that drives progress. Over the past decade, BioMarin Pharmaceutical Inc. and Protagonist Therapeutics, Inc. have demonstrated contrasting approaches to research and development (R&D) spending. BioMarin, a leader in the field, has consistently invested heavily in R&D, with expenditures peaking at approximately 750% more than Protagonist's highest annual spend. This commitment underscores BioMarin's dedication to pioneering new treatments and therapies. In contrast, Protagonist Therapeutics, while showing a steady increase in R&D spending, reached its highest investment in 2022, marking a significant 1600% increase from its 2014 levels. This growth trajectory highlights Protagonist's emerging focus on innovation. As the pharmaceutical landscape continues to shift, these companies' R&D strategies will play a crucial role in shaping their future success and impact on global health.
Merck & Co., Inc. or Protagonist Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Novartis AG vs BioMarin Pharmaceutical Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc.
Summit Therapeutics Inc. or Protagonist Therapeutics, Inc.: Who Invests More in Innovation?
BioMarin Pharmaceutical Inc. or Pharming Group N.V.: Who Invests More in Innovation?
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs Viridian Therapeutics, Inc.
Research and Development Investment: Madrigal Pharmaceuticals, Inc. vs Protagonist Therapeutics, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Protagonist Therapeutics, Inc.
MorphoSys AG or Protagonist Therapeutics, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Bausch Health Companies Inc. vs Protagonist Therapeutics, Inc.
Research and Development Expenses Breakdown: Amicus Therapeutics, Inc. vs Protagonist Therapeutics, Inc.
Analyzing R&D Budgets: Protagonist Therapeutics, Inc. vs Geron Corporation